• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

ContextVision

Less than 1K followers

CONTX

Oslo Børs

Medical Equipment & Services

Health Care

Overview
Investor consensus

ContextVision is a medical technology company. The company specializes in image analysis and artificial intelligence. The company's products include advanced image enhancement software for ultrasound, MRI, X-ray and mammography. The software is used by hospitals and research institutes worldwide. The company was founded in 1983 and is headquartered in Stockholm.

Read more
Market cap
-
Turnover
-
Revenue
120.53M
EBIT %
0.38 %
P/E
-
Dividend yield-%
-
Financial calendar
All
Press releases
ShowingAll content types

Forum discussions
Yleistä ContextVision AB (CONTX) on lääketieteellisiin kuva-analyysiratkaisuihin (algoritmeihin) erikoistunut yritys, ja sen liiketoiminnan ydintä ovat kuvankäsittely, tekoäly ja lääketieteellinen diagnostiikka sekä erityisesti näihin liittyvät ohjelmistoratkaisut. Yritys on sanojensa...
11/27/2023, 1:16 PM
by timontti
71
I also asked AI about the competitive landscape. There are plenty of them
11/27/2023, 5:33 PM
by timontti
6
Annual report published https://www.contextvision.com/contextvision-publishes-annual-report-for-the-fiscal-year-2023/ P.S. You can also add Norwegian companies to your watchlist through the Inderes service, even if they don’t have analyst coverage. At least you’ll get notifications...
4/12/2024, 9:07 AM
by timontti
3
Read more on our forum
Financial calendar
27.8
2026

Interim report Q2'26

5.11
2026

Interim report Q3'26

18.2
2027

Annual report '26

Regulatory press release5/12/2026, 2:35 PM

BULLETIN FROM THE ANNUAL GENERAL MEETING OF CONTEXTVISION AB (PUBL)

ContextVision
Regulatory press release5/11/2026, 3:34 PM

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release5/8/2026, 6:00 AM

ContextVision AB: Q1 interim report 2026 - Solid progress and disciplined execution in a stabilising market

ContextVision

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/29/2026, 3:14 PM

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release4/24/2026, 6:00 AM

Correction: Annual report financial calendar – Q1 interim report date

ContextVision
Regulatory press release4/20/2026, 3:16 PM

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release4/9/2026, 4:38 PM

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release4/8/2026, 6:00 AM

ContextVision publishes annual report for the fiscal year 2025

ContextVision
Press release4/7/2026, 3:35 PM

NOTICE TO THE ANNUAL GENERAL MEETING IN CONTEXTVISION AB (PUBL)

ContextVision
Regulatory press release4/7/2026, 5:30 AM

ContextVision cancels market-making agreement

ContextVision
Regulatory press release3/26/2026, 4:20 PM

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Press release3/26/2026, 12:00 PM

ContextVision partners with BeamWorks to advance AI-powered quantitative ultrasound imaging solutions

ContextVision
Regulatory press release3/17/2026, 6:05 PM

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release3/6/2026, 7:48 PM

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Press release3/2/2026, 6:30 AM

ContextVision announces changes to its management team and strengthens its technology leadership with appointment of new CTO

ContextVision
Regulatory press release2/25/2026, 4:04 PM

ContextVision AB: Transactions made under the buy-back programme

ContextVision
Regulatory press release2/19/2026, 9:02 AM

CONTX: Financial calendar

ContextVision
Regulatory press release2/19/2026, 7:00 AM

ContextVision AB: Year-end report 2025 – Substantial progress in transformation amid early signs of stabilization

ContextVision
Regulatory press release2/18/2026, 3:50 PM

ContextVision announces extended share buy-back programme

ContextVision
Regulatory press release2/16/2026, 4:16 PM

ContextVision AB: Transactions made under the buy-back programme

ContextVision